Celon Pharma S.A. - Penyata Pendapatan (TTM)

Celon Pharma S.A.
GB ˙ LSE
Penyata Pendapatan (TTM)

Celon Pharma S.A. Penyata Pendapatan menunjukkan perubahan dalam pendapatan dan perbelanjaan sepanjang tempoh masa tertentu. Data Penyata Pendapatan termasuk Jualan dan Hasil, Untung Kasar, Penyelidikan dan Pembangunan (R&D), Jualan, Perbelanjaan Am dan Pentadbiran (SG&A), Pendapatan Operasi, Perbelanjaan Cukai Pendapatan, Perbelanjaan Faedah, Pendapatan Bukan Operasi, Perolehan sesaham (EPS), dan Saham Diterbitkan.

Semua nombor adalah kali 1,000,000 kecuali setiap unit saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
Hasil 142 157 170 185 186 196 191 186 191 194 196 211 214 214 209 207 210 205 215
Perubahan (%) 10.80 7.98 8.53 0.99 5.23 -2.53 -2.49 2.68 1.32 1.02 7.74 1.63 -0.26 -2.16 -1.12 1.32 -2.24 4.94
% daripada Hasil 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Kos jualan 43 37 45 51 51 62 59 61 68 66 72 68 69 67 61 63 64 63 69
Perubahan (%) -14.14 23.66 13.37 -1.13 21.50 -4.48 3.56 10.72 -1.68 8.77 -5.41 1.62 -3.85 -8.57 2.54 2.33 -1.46 9.83
% daripada Hasil 30.03 23.27 26.65 27.84 27.26 31.47 30.84 32.76 35.32 34.28 36.91 32.40 32.40 31.24 29.19 30.27 30.57 30.82 32.25
Keuntungan Operasi Kasar 99 121 125 133 136 134 132 125 124 127 124 143 145 147 148 144 146 142 146
Perubahan (%) 21.50 3.22 6.77 1.81 -0.87 -1.64 -5.19 -1.24 2.96 -3.03 15.44 1.64 1.46 0.75 -2.63 0.88 -2.58 2.76
% daripada Hasil 69.97 76.73 73.35 72.16 72.74 68.53 69.16 67.24 64.68 65.72 63.09 67.60 67.60 68.76 70.81 69.73 69.43 69.18 67.75
SG&A 72 83 91 86 89 90 96 100 108 108 111 108 108 111 110 119 121 121 125
Perubahan (%) 16.63 9.00 -5.21 3.16 1.33 6.86 4.09 7.52 -0.06 2.68 -2.18 0.04 2.68 -0.84 8.16 1.29 0.64 3.15
% daripada Hasil 50.34 52.99 53.49 46.72 47.72 45.96 50.38 53.78 56.32 55.55 56.46 51.26 50.46 51.94 52.65 57.59 57.57 59.26 58.25
R&D -10
Perubahan (%)
% daripada Hasil -6.09
OpEx 142 162 171 188 197 207 213 218 229 232 243 238 240 242 236 251 188 258 269
Perubahan (%) 13.88 6.10 9.81 4.46 5.12 3.16 2.48 4.71 1.31 4.64 -1.88 0.72 1.08 -2.74 6.68 -25.29 37.33 4.31
% daripada Hasil 99.83 102.60 100.82 102.00 105.51 105.40 111.55 117.24 119.56 119.55 123.83 112.77 111.75 113.25 112.59 121.46 89.57 125.82 125.07
Pendapatan operasi 0 -4 -1 -4 -10 -11 -22 -32 -37 -38 -47 -27 -25 -28 -26 -44 22 -53 -54
Perubahan (%) -1,749.74 -66.20 166.81 177.45 3.17 108.60 45.52 16.48 1.25 23.17 -42.26 -6.48 12.48 -7.10 68.61 -149.25 -341.99 1.87
% daripada Hasil 0.17 -2.60 -0.82 -2.00 -5.51 -5.40 -11.55 -17.24 -19.56 -19.55 -23.83 -12.77 -11.75 -13.25 -12.59 -21.46 10.43 -25.82 -25.07
Perbelanjaan Faedah -1 -1 -1 -1 -1 -2 -2 -2 -2 -2 -2 -2 -3 -3 -3 -3 -2 -2 -2
Perubahan (%) 19.94 11.69 25.50 1.50 63.65 28.78 -19.30 14.13 -9.28 9.69 35.24 8.23 -0.78 -5.56 -0.40 -5.83 4.83 -5.50
% daripada Hasil -0.39 -0.42 -0.44 -0.51 -0.51 -0.79 -1.05 -0.87 -0.96 -0.86 -0.94 -1.17 -1.25 -1.24 -1.20 -1.21 -1.12 -1.21 -1.09
Pendapatan bersih 4 -1 -0 -2 -11 -12 -17 -28 -31 -39 -47 -30 -25 -28 -28 -45 19 -34 -44
Perubahan (%) -120.67 -83.32 943.79 603.76 3.27 49.94 58.20 13.94 25.20 20.29 -36.52 -16.18 11.87 0.67 60.64 -140.70 -286.10 27.33
% daripada Hasil 3.12 -0.58 -0.09 -0.87 -6.03 -5.92 -9.11 -14.77 -16.39 -20.26 -24.12 -14.21 -11.72 -13.15 -13.53 -21.98 8.83 -16.80 -20.39

Source: Capital IQ

Other Listings
DE:8RP €4.97
PL:CLN
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista